Lightfield Medical, Inc.
Lightfield Medical, Inc.33
About
What does Lightfield Medical, Inc. do?
Lightfield Medical, Inc. is a startup focused on revolutionizing medical imaging through the application of light-field technology. Their innovative approach aims to provide enhanced depth perception and volumetric imaging capabilities, potentially leading to more accurate diagnoses and improved patient outcomes in various medical fields.
Where is Lightfield Medical, Inc. headquartered?
Lightfield Medical, Inc. is headquartered in San Carlos, United States.
When was Lightfield Medical, Inc. founded?
Lightfield Medical, Inc. was founded in 2017.
What industry does Lightfield Medical, Inc. operate in?
Lightfield Medical, Inc. operates in MedTech, HealthTech, Medical Imaging, Optics, Hardware, Biotech.
An AI copilot for doctors that provides immediate, evidence-based answers to clinical questions from peer-reviewed medical sources.
Aetios AI builds advanced clinical tools for mental health professionals, leveraging AI for psychological formulation and treatment planning.
Ship of Theseus is developing a fleet of biologics based on the homeobox (HOX) family of transcription factors to create novel pharmaceuticals.
Medbytes provides doctors with a personalized platform for high-impact medical research and news in their specialty.
Provider-supervised peptide therapy, NAD+ support, and cognitive enhancement for cellular renewal, recovery, and healthy aging.
Your health consultation for a pain-free life, offering pain management and therapy solutions.
An AI-powered platform for cancer patients and survivors in Asia to navigate care and understand their diagnosis.
AI-powered personalized sleep coaching and actionable insights for improving sleep quality.
An entrant is a company tagged MedTech whose domain was first registered in the window, counted from registry records in the StartupHub directory. 4 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.